Oct 28 (Reuters) - The U.S. Food and Drug Administration
has issued a warning letter to Philips after
inspections at three of its medical device facilities found they
had failed to meet required manufacturing standards, according
to an update on the agency's website on Tuesday.
(Reporting by Sruthi Narasimha Chari and Kamal Choudhury in
Bengaluru)